rs7042788
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1
The NM_003863.4(DPM2):āc.64A>Gā(p.Thr22Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00018 in 1,613,386 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T22I) has been classified as Uncertain significance.
Frequency
Consequence
NM_003863.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DPM2 | NM_003863.4 | c.64A>G | p.Thr22Ala | missense_variant | 2/4 | ENST00000314392.13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DPM2 | ENST00000314392.13 | c.64A>G | p.Thr22Ala | missense_variant | 2/4 | 1 | NM_003863.4 | P1 | |
ENST00000592240.5 | n.143+2818T>C | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00109 AC: 165AN: 151806Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000243 AC: 61AN: 250794Hom.: 0 AF XY: 0.000170 AC XY: 23AN XY: 135586
GnomAD4 exome AF: 0.0000862 AC: 126AN: 1461462Hom.: 0 Cov.: 30 AF XY: 0.0000688 AC XY: 50AN XY: 727022
GnomAD4 genome AF: 0.00109 AC: 165AN: 151924Hom.: 1 Cov.: 33 AF XY: 0.00117 AC XY: 87AN XY: 74258
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 07, 2019 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 12, 2020 | - - |
Congenital muscular dystrophy with intellectual disability and severe epilepsy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
DPM2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 28, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at